Showing results (1631-1640 of 1,711) with videos related to
Sort By:
Pageof 172
Circulation|March 19, 2019
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes MellitusEri T Kato, Michael G Silverman, Ofri Mosenzon, et al.Gut|February 18, 2021
Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trialGeltrude Mingrone, Annieke Cg van Baar, Jacques Devière, et al.Journal of the American College of Cardiology|August 27, 2025
A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular RiskPaul M Haller, Giorgio E M Melloni, David D Berg, et al.JACC. Cardiovascular Interventions|June 17, 2019
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary InterventionDirk Sibbing, Daniel Aradi, Dimitrios Alexopoulos, et al.The Lancet. Diabetes & Endocrinology|July 6, 2019
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trialKausik K Ray, Helen M Colhoun, Michael Szarek, et al.Journal of the American College of Cardiology|September 3, 2025
Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial ParticipantsSean J Jurgens, Giorgio E M Melloni, Shinwan Kany, et al.Lancet (London, England)|June 29, 2020
Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trialRaj R Makkar, Wen Cheng, Ron Waksman, et al.Journal of the American College of Cardiology|November 19, 2021
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCIMarco Valgimigli, Davide Cao, Dominick J Angiolillo, et al.American Heart Journal|September 20, 2005
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt, Keith A Fox, Werner Hacke, et al.European Journal of Preventive Cardiology|December 6, 2023
Serial troponin-I and long-term outcomes in subjects with suspected acute coronary syndromeManan Pareek, Anna Meta Dyrvig Kristensen, Muthiah Vaduganathan, et al.Pageof 172